National

Pune institute para Oxford’s COVID-19 vaccine laga domestic clinical trials shuru kuribole ase

July 21, 2020: Pune based vaccine manufacturer Serum Institute of India (SII)  para Monday te koishe  tai khan para ekta license nimete apply kuribo Indian drug regulator laga haath para Oxford University’s experimental COVID-19 vaccine laga clinical  trails shuru kuribole nimete ek haafta bithor te .

Etu  move kura toh  etu vaccine AZD1222 pharmaceutical company AstraZeneca para bona toh University of Oxford khan researchers khan   para  interim  trials te positive results dikha nimete.

Etu vaccine toh  manu khan chulabole nimete safe thakishe   aro etu para  protective immune response bhal hobo    participants khan nimete kun khan ke etu laga  dose diya pichede .

SII Chief Executive Officer Adar Poonawalla koishe  k”etu trials para  bishi bhal results khan dikhaishe   aro ami khan etu nimete bishi khushi ase  ami khan  Indian regulator  logote ek haafta bithor te licensure trials mangibole  ase.”

Tai aro koishe”etu permission paa logote ami khan  para India  laga  vaccine  nimete trials lobole ase .etu logote ami khan  joldi hi   vaccine  khan bishi olabole kuribole ase.

AstraZeneca toh nouta companies logote partner kurishe  duniya te aro  etu vaccine  ek bar tayar hoishe koile toh olabole nimete ami khan 2 billion doses olabole shuru kuribo.

India’s Serum Institute, duniya  laga largest vaccine manufacturer ke chunishe   Oxford aro  tai laga partner AstraZeneca para etu vaccine   toh olabole nimete  etu tayar thaka pichede.

medical journal The Lancet  te  experimental COVID-19 vaccine  laga interim trials laga results toh oalishe.

MenePangalos, executive vice president BioPharmaceuticals Research and Development AstraZeneca  ki ”ami khan Phase I/II interim data AZD1222 para rapid antibody and T-cell response SARS-CoV-2 laga khilaaf dibole para nimete mondangor hoishe.”

Tai aro koishe ki”aro bi kaam kuribole thaka nimete aji laga  data  para ami khan laga mondangor kurishe ke etu vaccine  toh kaam kuribo aro etu para ami khan  pklans khan jai thakibo etu  vaccine olabole nimete  broad aro equiable access nimete.”

experimental COVID-19 vaccine trials laga next phase  toh etia jai ase UK, Brazil and South Africa te aro US te etia tak shuru huwanai .